MAP2K1 and melanoma: We find that PREX2 loss or mutation strongly cooperates with MEK1/2 inhibition, in a manner phenocopied by, and epistatic to, inhibition p110β/δ, to suppress growth of complex melanoma models, in a genotype-specific manner both in vitro and in vivo.